Supply of Medicine and Medical / Surgical equipments : Bacillus Calmette-Guerin Vaccine (BCG) 20\ndose vial (with a suitable diluent)\nBacillus Calmette-Guerin vaccine (BCG) 20\ndose Vial\nBacillus Calmette-Guerin vaccine BP or USP\n(BCG Vaccine)\nEach infant (<1 year old) dose should contain\n0.025mg of live Bacillus Calmette - Guerin and\nwhen reconstituted, the dose should be 0.05mL\n1.Offers should be only from vaccine suppliers\nrecommended by World Health Organization\n(WHO) for bulk purchase for the UN Agencies.\n2. The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis, lot\nrelease certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production and\nquality control test data should be submitted for\nprotocol review.\n3. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n4. The vaccine should also comply with the\ngeneral requirements for vaccines in the BP or\nUSP.\n5. The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\n6. Vaccine should be stored at a temperature\nof 2'C-8'C. Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack during\ndelivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\n7. Each vial to be provided with a suitable\nsterile diluent.\n8. Each vial should contain a suitable vaccine\nvial monitor.\n9. Must be a WHO prequalified product. etc .

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Sri Lanka has Released a tender for Supply of Medicine and Medical / Surgical equipments : Bacillus Calmette-Guerin Vaccine (BCG) 20\ndose vial (with a suitable diluent)\nBacillus Calmette-Guerin vaccine (BCG) 20\ndose Vial\nBacillus Calmette-Guerin vaccine BP or USP\n(BCG Vaccine)\nEach infant (<1 year old) dose should contain\n0.025mg of live Bacillus Calmette - Guerin and\nwhen reconstituted, the dose should be 0.05mL\n1.Offers should be only from vaccine suppliers\nrecommended by World Health Organization\n(WHO) for bulk purchase for the UN Agencies.\n2. The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis, lot\nrelease certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production and\nquality control test data should be submitted for\nprotocol review.\n3. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n4. The vaccine should also comply with the\ngeneral requirements for vaccines in the BP or\nUSP.\n5. The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\n6. Vaccine should be stored at a temperature\nof 2'C-8'C. Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack during\ndelivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\n7. Each vial to be provided with a suitable\nsterile diluent.\n8. Each vial should contain a suitable vaccine\nvial monitor.\n9. Must be a WHO prequalified product. etc . in Pharmaceuticals. The tender was released on Mar 20, 2025.

Country - Sri Lanka

Summary - Supply of Medicine and Medical / Surgical equipments : Bacillus Calmette-Guerin Vaccine (BCG) 20\ndose vial (with a suitable diluent)\nBacillus Calmette-Guerin vaccine (BCG) 20\ndose Vial\nBacillus Calmette-Guerin vaccine BP or USP\n(BCG Vaccine)\nEach infant (<1 year old) dose should contain\n0.025mg of live Bacillus Calmette - Guerin and\nwhen reconstituted, the dose should be 0.05mL\n1.Offers should be only from vaccine suppliers\nrecommended by World Health Organization\n(WHO) for bulk purchase for the UN Agencies.\n2. The product should be from fresh stocks\nand each consignment should be prepared\npreferably from a single batch. Each batch\nshould accompany a certificate of analysis, lot\nrelease certificate issued by a laboratory\naccredited by National Control Authority and\nSummary Protocol of vaccine production and\nquality control test data should be submitted for\nprotocol review.\n3. Each consignment should have a minimum\nremaining shelf life of 75% at the time of\nreceiving the consignment at MSD.\n4. The vaccine should also comply with the\ngeneral requirements for vaccines in the BP or\nUSP.\n5. The vaccine should meet the most recent\nrequirements of WHO when tested by the\nmethods outlined by WHO.\n6. Vaccine should be stored at a temperature\nof 2'C-8'C. Cold chain monitors or WHO\nrecommended other cold chain monitoring\ndevice should be included in each pack during\ndelivery and the cold chain should be\nmaintained during storage, transport and\ndelivery of vaccines.\n7. Each vial to be provided with a suitable\nsterile diluent.\n8. Each vial should contain a suitable vaccine\nvial monitor.\n9. Must be a WHO prequalified product. etc .

Deadline - Apr 30, 2025

GT reference number - 105339257

Product classification - Pharmaceutical products